Amgen says Phase 1 AMG 513 obesity study placed on clinical hold by FDA
Amgen (AMGN) provided updates on selected product and pipeline programs, including that a Phase 1 study of AMG 513 in people living with ...
Pharmaceutical Technology21d
Balstilimab by Agenus for Gastric Cancer: Likelihood of Approval
gastric cancer, breast cancer, prostate cancer, bladder cancer, head & neck SCC, sarcoma and pancreatic cancer. The therapeutic candidate is administered intravenously. The drug candidate is ...
The New England Journal of Medicine1mon
Occurrence in Gastric Juice of Antibody to a Complex of Intrinsic Factor and Vitamin B
A stool stained for fat with Sudan III was unremarkable. The pH of the gastric juice was 8.0 after stimulation with betazole hydrochloride (Histalog). The gastric juice contained no intrinsic ...
Pharmaceutical Technology1mon
Ivonescimab by Akeso for Gastric Cancer: Likelihood of Approval
Ivonescimab is under clinical development by Akeso and currently in Phase II for Gastric Cancer. According to GlobalData ... The therapeutic candidate is a bi-specific antibody targeting programmed ...